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PREVALENCE OF RETINOPATHY IN PATIENTS OF THE
COMPREHENSIVE DIABETES PROGRAM OF THE SAN GENARO
DE VILLA HEALTH CENTER, CHORILLOS, LIMA-PERU
PREVALENCIA DE RETINOPATIA EN PACIENTES DEL PROGRAMA INTEGRAL DE DIABETES DEL
CENTRO DE SALUD SAN GENARO DE VILLA, CHORRILLOS, LIMA-PERÚ
John Longa-López 1,a, Miguel Mavila-Salon 2,b, Luis Rodriguez-Dominguez 2,b

ABSTRACT
Objectives: To determine the prevalence of retinopathy in patients of the Comprehensive Diabetes Program of
the San Genaro de Villa Health Center, Chorrillos. Methods: Descriptive, observational, cross-sectional,
prospective study; with a sample of 119 adults and older adults. Non-probabilistic convenience sampling was
used. The variables studied were diabetic retinopathy, type of diabetic retinopathy, degree of diabetic
retinopathy, age, sex, educational level, time of illness, time belonging to the program, type of treatment,
personal history of arterial hypertension, personal history of dyslipidemia, mean systolic blood pressure (SBP),
mean diastolic blood pressure (DBP), Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Total
Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, creatinine clearance, microalbuminuria, visual
eﬃciency of Snell-Sterling, associated ocular pathology and ocular pressure. Descriptive statistical methods
were used. Results: The prevalence of diabetic retinopathy (DR) was 16%, of which 73.7% is non-proliferative
DR, 21.2% proliferative DR, and 5.2% macular edema, and in relation to the degrees of Non-Proliferative DR 60%
is mild, 33.3% moderate and 6.7% severe and in Proliferative DR 33.3% is early, 33.3% high risk and 33. 3%
Severe. The biochemical value that showed a considerable diﬀerence was microalbuminuria, reaching a value
of 356.93 mg/dl/24hrs. Conclusion: The prevalence of retinopathy is 16%, of which 73.7% is nonproliferative
retinopathy, 21.2% proliferative retinopathy, and 5.2% macular edema.
Keywords: Prevalence; Diabetic retinopathy; Diabetes mellitus. (Source: MeSH NLM)

RESUMEN
Objetivos: Determinar la prevalencia y los factores asociados a retinopatía en pacientes del Programa Integral de
Diabetes del Centro de Salud San Genaro de Villa Chorrillos. Métodos: Estudio descriptivo, observacional, transversal,
prospectivo; con una muestra de 119 adultos y adultos mayores. Se utilizo el muestreo no probabilístico por
conveniencia. Las variables estudiadas fueron retinopatía diabética, Tipo de retinopatía diabética, grado de
retinopatía diabética, edad, sexo, grado de instrucción, tiempo de enfermedad, tiempo de pertenencia la programa,
tipo de tratamiento, antecedente personal de hipertensión arterial, antecedente personal de dislipidemia, presión
arterial sistólica (PAS) promedio, presión arterial diastólica (PAD) promedio, Índice de masa corporal (IMC),
Hemoglobina Glicosilada (HbA1c), Colesterol total, Colesterol LDL, Colesterol HDL, Triglicéridos, depuración de
creatinina, microalbuminuria, e ciencia visual de Snell-Sterlling, patología ocular asociada y presión ocular. Se
emplearon métodos estadísticos descriptivos. Resultados: La prevalencia de retinopatía diabética (RD) fue de 15,1%
de los cuales el 77,8% es RD No proliferativa y el 22,2% RD proliferativa. En relación a los grados en la RD No
Proliferativa el 64,3% es leve y el 35,7% moderada; y en la RD Proliferativa el 25% es temprana, el 25% de alto riesgo y el
50% severa. El valor bioquímico que mostro una considerable diferencia fue la microalbuminuria alcanzando un valor
de 356,9 mg/dl/24hrs. Conclusiones: La prevalencia de retinopatía es de 15,1% de los cuales el 77,8%% es retinopatía
no proliferativa y de 22,2% retinopatía proliferativa y los factores asociados fueron la presión arterial sistólica
(p<0,001) y la microalbuminuria (p<0,001).
Palabras Claves: Prevalencia; Retinopatía diabética; Diabetes mellitus. (Fuente: DeCS BIREME)
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INTRODUCTION
Diabetic retinopathy (DR) is the leading cause of new
cases of legal blindness among adults 20 to 74 years of
age in the United States (1). Vision loss due to diabetic
retinopathy occurs through a variety of mechanisms,
including retinal detachment, vitreous or premacular
hemorrhage, associated neovascular glaucoma, and
macular edema (2). The presence of retinopathy can
indicate a dysfunction in the microcirculation of other
organs and systems (3,4). Therefore, investigating the
prevalence of diabetic retinopathy is important since it
constitutes a key indicator of systemic microvascular
complications and a sentinel indicator of the incidence
of diabetes.
In our country, according to the epidemiological
surveillance system of Diabetes 2021 of the National
Center for Epidemiology, prevention, and control of
diseases of 96 hospitals, 62 health centers, 153 health
posts, and two reporting polyclinics, only 26.31% had
results of the evaluation of macro and microvascular
complications, 6.94% corresponding to diabetic
retinopathy. As we can see, there is an under-evaluation
and under-reporting of one of the complications with
the highest impact on the quality of life of patients with
diabetes mellitus.

The current evidence shows that the increase in health
costs is associated with the progression of retinopathy
(6)

and cost-eﬀectiveness studies tip the balance in favor

of annual screening for diabetic retinopathy and
subsequent treatment in type one and two diabetics
compared with no screening (7,8). If all patients with type
two diabetes receive the recommended treatment, the
net projected savings are greater than $472.1 million
and 94,304 vision-related person-years. Including each
additional person with type two diabetes in current
recommended eye care results in an average net
savings of $975 per person, even if all care costs are
borne by the federal government (9).
The vast majority of patients who develop diabetic
retinopathy do not present symptoms until very late
stages (by which time it may be too late for eﬀective
treatment). There is evidence that retinopathy begins to
develop seven years before the clinical diagnosis of
type two diabetes mellitus (10). Because the rate of
progression may be rapid, and therapy may be
bene cial in both improving symptoms and reducing
the rate of disease progression, periodic evaluation of
patients with diabetes mellitus is important to prevent
retinal disease development.

It is important to mention that showing the presence of
retinopathy among the rst causes of outpatient
c o n s u l t a t i o n s h ow s u s a n i n d i c a t i o n o f t h e
repercussions of the epidemiological transition in the
country, that is, the increase in non-communicable
diseases to communicable ones. The prevalence of
Diabetic Retinopathy increases with the duration of
diabetes. In the Wisconsin Epidemiologic Study of
Diabetic Retinopathy (WESDR), the prevalence of
retinopathy in patients with early onset was 8% at three
years, 25% at ve years, 60% at ten years, and 80% at 15
years.

In conclusion, diabetic retinopathy constitutes a
nosological entity whose resizing and clinicalepidemiological characterization is transcendental due
to its economic, social, etc., impact. that it involves, but
also because of the implications that its identi cation
entails in decision-making in public health, especially in
scenarios such as the health jurisdiction of the San
Genaro de Villa Health Center, a primary care facility that
covers a diabetic population in whose A set of health
determinants come together, whose dynamic
interaction is essential to elucidate in order to be able to

At the Wilmer Ophthalmological Institute of the
University, Johns Hopkins in Baltimore, it was shown
that the cost to avoid blindness due to proliferative DR
in insulin-dependent patients would be 966 dollars per
person per year and to preserve central vision due to
macular edema would be 1118 dollars annual. This
would represent one-seventh of the average cost of a
year of social security for the visually impaired (5).
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implement prevention strategies at all levels.

METHODS
Design and Study Area
A descriptive, observational, cross-sectional study was
conducted. The investigation was carried out in the San
Genaro de Villa health center located in the District of
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Chorrillos, category I-three where preventivepromotional and assistance activities are carried out. In
November 2005, the Comprehensive Diabetes Program
of the San Genaro de Villa Health Center, a program that
was born as a local strategy within the Framework of the
Comprehensive Health Care Model and that at the date
of the study has 120 patients, who have been
progressively enrolled within a comprehensive and
holistic management strategy, before the COVID 19
pandemic.

Population and Sample
The study population was made up of all adults and
older adults of both sexes diagnosed with type two
diabetes mellitus, belonging to the Comprehensive
Diabetes Program of the San Genaro de Villa Health
Center during the period of the present investigation,
which amounted to 120. The sampling for the present
investigation was of a non-probabilistic type for
convenience since all the patients who met the
inclusion and exclusion criteria were included, these
119 patients.

Variables and Instrument
The variables that were studied were:
-Diabetic Retinopathy, in ammatory disease of the
retina related to diabetes
-Types of Diabetic Retinopathy, characterization of
retinopathy according to clinical ndings and
according to previously established criteria
-Grades of Diabetic Retinopathy, determination of
the degree of severity of retinal damage for prognostic
and therapeutic purposes
-Sex characteristics of individuals who identify as male
or female.
-Age is de ned as the number of years, months, and
days completed on the instrument's application date.
-Level of education: Degree of the academic level
reached
-Time of illness: Years elapsed from the medical
diagnosis of diabetes mellitus to the date of the
interview
-Time of belonging to the program: Years elapsed
from enrollment in the Program to the date of the
interview
-Type of Treatment: It is the name of the medication
prescribed and consumed for therapeutic purposes
-Personal History of AHT: It is the prior knowledge by
the patient of suﬀering from a disease
-Personal History of Dyslipidemia: It is the prior
knowledge by the patient of suﬀering from a disease
-Systolic Blood Pressure (SBP): It is the maximum
value of blood pressure in systole.
- Diastolic Blood Pressure (DBP): It is the minimum
value of blood pressure when the heart is in diastole
- Body Mass Index (BMI): It is the measure of
association between weight and height of a person to
assess their nutritional status.

- Glycosylated Hemoglobin: Heteroprotein of the
blood that results from the union of Hb with free
carbohydrates attached to carbon chains with acid
functions in carbon three and four. It is used to evaluate
the degree of metabolic control of diabetes in the last
three to four months.
- Total Cholesterol: It is the cholesterol present in the
plasmatic lipoproteins that are in the fasting state; that
is, it represents the cholesterol carried by the
lipoproteins: HDL, VLDL, and LDL.
- LDL Cholesterol: Low-density lipoproteins with
atherogenic capacity.
- HDL Cholesterol: It is the cholesterol found only in the
HDL lipoprotein. It evaluates the body's ability to
remove excess cholesterol from the periphery.
Triglycerides are mainly represented in the VLDL
lipoprotein because, in basal conditions, there are no
chylomicrons, and HDL and LDL carry very little TG. This
test evaluates the hepatic synthesis of VLDL.
-Creatinine Clearance Creatinine clearance allows the
evaluation of the glomerular ltration rate by relating
the determination of urinary and serum creatinine.
- Microalbuminuria: is the urinary excretion of albumin
and is a marker of early kidney disease.
- Visual Eﬃciency: The degree of eﬃciency of the vision
to perceive, detect or identify spatial objects with good
lighting conditions.
- Associated Ocular Pathology: Diseases that
compromise the diﬀerent structures of the eye.
- Ocular Pressure: The pressure exerted by the ocular
uids against the wall of the eye is necessary for this
organ to remain distended.
The instrument used in the present investigation
corresponded to a Data Collection Sheet, which
consisted of 28 items , among which the study variables
were included.

Procedure
In the data collection form, the information on the
variables: level of education, time of illness, time
belonging to the program, type of treatment, personal
history of arterial hypertension and personal history of
dyslipidemia were obtained through the interview
technique. ; The date of birth (which was used to
calculate the patient's chronological age) and sex were
recorded from the national identity document (DNI) of
the interviewee. On the other hand, the variables:
systolic blood pressure (SBP), diastolic blood pressure
(DBP), weight, and height were obtained by direct
measurement, being the body mass index (BMI)
calculated from the data recorded in the weight and
height of the patient. patient. Regarding the variables:
glycosylated hemoglobin (HbA1c), total cholesterol,
LDL cholesterol, HDL cholesterol, triglycerides,
creatinine clearance, and microalbuminuria, the
corresponding biochemical laboratory analyzes were
recorded. Regarding the variables: visual acuity and
Pág. 524

Published by INICIB-URP, 2021

3

Revista de la Facultad de Medicina Humana, Vol. 22 [2021], Iss. 3, Art. 9

ocular pressure were were obtained from the clinical

variables, the measures of central tendency used, and in

evaluation carried out by an ophthalmologist who, in

the case of categorical variables, the distribution of

turn, recorded the associated ocular pathology. To the

frequencies.

visual eﬃciency variable, was obtained through the
Snell Sterling visual acuity equivalencies. Finally, for the
variables: prevalence of retinopathy, type of
retinopathy, and degrees of retinopathy, the
corresponding uorescein angiography evaluated by
an ophthalmologist with a retina subspecialty was
recorded.

Ethical Aspects
Approval was obtained from the ethics committee of
the Postgraduate School of the Federico Villarreal
National University

RESULTS

Statistical Analysis

In this graph It can be seen that of 119 subjects

The data obtained in the present investigation were

diagnosed with type II diabetes mellitus evaluated, 19

processed using the statistical package PASW version

of them have Diabetic Retinopathy, which corresponds

18.0. For the analysis of the variables, descriptive

to 16% of the total evaluated, therefore the remaining

statistics were used, being in the case of quantitative

84% did NOT present Diabetic Retinopathy.

Table 1. Prevalence of retinopathy according to clinical, epidemiological characteristics of the
Comprehensive Diabetes Program of CS San Genaro de Villa, Chorrillos.

With Diabetic
Retinopathy

Without Diabetic
Retinopathy

62.68 years

58.30 years

26.3% (5)

17% (17)

73.7 % (14)

83% (83)

None

15.8% (3)

16% (16)

Primary

36.8% (7)

42% (42)

Secondary

42.1% (8)

42.1% (8)

0%

0%

5.3% (1)

5.3% (1)

Time of illness

7.87 years

7.87 years

Time belonging to
the program

2.53 years

2.53 years

Average
Sex
Male
Female
Level of Instruction

Techn. Superior
University
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With Diabetic
Retinopathy

Without Diabetic
Retinopathy

Type of Treatment
89.5% (17)

90%(90)

0%

2%(2)

10.5% (2)

8% (8)

Yes

52.6% (10)

26.3%(26)

No

47.4% (9)

73.7% (73)

Yes

57.9% (11)

48.5%(48)

No

42.1% (18)

51.5%(51)

Systolic

154.47mmHg

133.94mmHg

Diastolic

74.21mmHg

69.82mmHg

BMI

27.72 kg/m2

29.30 kg/m2

8.44

%

Cholesterol Total

197.57 mg/dl

199.02 mg/dl

LDL

125.07 mg/dl

125.02 mg/dl

HDL

39.81 mg/dl

38.52 mg/dl

Triglycerides

176.00 mg/dl

187.83 mg/dl

Creatinine clearance

90.36 ml/min

112.13 ml/min

Microalbuminuria

35 mg/dl/24h

36.74 mg/dl/24h

Right Eye

79.78%

82.55%

Left Eye

73.52%

89.40%

Right Eye

15.56mmHg

15.94mmHg

Left Eye

15.78mmHg

16.45mmHg

52.6% (10)

25% ( 25)

0%

10% (10)

Catarata + Glaucoma

5.3% (1)

6% (6)

Others/none

42.1% (8)

59% (59)

ADO
Insulin
ADO + Insulin
History of Arterial Hypertension

History of Dyslipidemia

Blood Pressure

HbAc1

Visual Eﬃciency

Ocular Pressure

Associated ocular pathology
Cataract
Glaucoma
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100

2 (6,3%)

30 (93,8%)

32 (100,0%)

104

1 (7,7%)

12 (92,3%)

13 (100,0%)

Eﬁciencia Visual OI

1 (50,0%)

1 (50,0%)

2 (100,0%)

1 (50,0%)

1 (50,0%)

2 (100,0%)

1 (100,0%)

0 (0,0%)

1 (100,0%)

0 (0,0%)

3 (100,0%)

3 (100,0%)

1 (11,1%)

8 (88,9%)

9 (100,0%)

0 (0,0%)

1 (100,0%)

1 (100,0%)

1 (12,5%)

7 (87,5%)

8 (100,0%)

1 (14,3%)

6 (85,7%)

7 (100,0%)

91

4 (25,0%)

12 (75,0%)

16 (100,0%)

96

3 (17,6%)

14 (82,4%)

17 (100,0%)

100

4 (11,8%)

30 (88,2%)

34 (100,0%)

104

1 (7,7%)

12 (92,3%)

13 (100,0%)

Ojo derecho

15,5±3,2

16,0±3,5

15,9±3,5

0,55

Ojo izquierdo

15,9±2,4

16,4±3,3

16,4±3,2

0,47

0
3
20

0,39

49
58
70
76
84

Presión Ocular (mmHg)

0,16

Patología ocular asociada
Catarata

9 (25,7%)

26 (74,3%)

35 (100,0%)

Glaucoma

0 (0,0%)

10 (100,0%)

10 (100,0%)

Catarata + Glaucoma

1 (14,3%)

6 (85,7%)

7 (100,0%)

Otros/ninguno

8 (11,9%)

59 (88,1%)

67 (100,0%)

In this table, the prevalence of Diabetic Retinopathy can be observed according to the clinical epidemiological
characteristics studied in this investigation .
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DISCUSSION
In this investigation, the determination of the
prevalence of diabetic retinopathy in the group studied
was 16% , this gure is lower than that reported by the
National Health and Nutrition Survey III (NHANES III)
from 2005 to 2008 in the United States in the 28.5% of
retinopathy is reported in the diabetic population.
On the other hand, the literature refers to the in uence
of some genetic and ethnic factors in the
pathophysiology and natural history of diabetic
retinopathy. These fac tors could explain the
epidemiological variability in the frequency of
presentation of said event. However, studies carried out
in the Peruvian population, such as that of Juan Amaral
et al. (11) , who evaluated 849 patients from the Social
Security Diabetes Mellitus Program in the city of Piura,
found a prevalence of 30%.
This gure does not diﬀer much from the one found by
Teresa Mendizábal et al. (12) who evaluated 48 patients
from the Endocrinology Service of the Daniel Alcides
Carrión Hospital in the city of Lima, nding a 26%
prevalence of diabetic retinopathy. These gures

reported at the national level are even higher than the
one found in the present investigation, which can be
explained due to the sample size of the diﬀerent
investigations referred to, as well as the factor related to
the type of population included in the present
investigations and the methodology used in the
diagnosis which makes statistical comparisons diﬃcult.
Concerning the prevalence of the diﬀerent types of
diabetic retinopathy, as we can see, Non-Proliferative
Retinopathy is the most frequent with 73.7% followed
by Proliferative with 21.1% and 5.2% presenting with
Edema. Macular.
These gures coincide with what was reported by Juan
Amaral Luna et al.(11) in the Piuran population of our
country, which refers to a prevalence of NonProliferative Retinopathy of 81% as well as 19% of
Proliferative Retinopathy, however, they report a higher
proportion of Macular edema of the order of 35%, much
higher than the gure found by our research. Feng Wua
Huang et al.(13) in the Chinese population coincidentally
found a prevalence of Macular Edema of 5.2%, equal to
that reported in our research.

Figure 1. Severe Nonproliferative Diabetic Retinopathy.
Pink ANOON, small papillary excavation, applied retina, decreased macular brightness with retinal thickening
and exudates aﬀecting the entire macula, microaneurysms distributed in four quadrants.
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When we look at the prevalence of Diabetic retinopathy
according to age, we can see that the average age of
patients with diabetic retinopathy is greater than that of
those who do not present the microvascular
complication, being able to observe that the age group
of older adults has a higher proportion of cases of
retinopathy than the group of adults who belong to the
Comprehensive Diabetes Program of CS San Genaro de
Villa. These frequency data are related to what was
found by Afra A Al-Sarraf et al. (14) , who in their study
“Prevalence and Factors Associated with Diabetic
Retinopathy, a Multi-centric Study in Kuwait” reports
that of the personal factors examined, age was the only
signi cant determinant of diabetic retinopathy (OR=
2.2, 95% CI: 1.1-5.2) as well as the age groups 50 to 59
and > 60 years compared with those under 40 years of
age (OR= 4.6, 95% CI 2.0-11.0).

When we describe the prevalence of diabetic
retinopathy according to the sex of the patients
evaluated, we can see that although it is true that the
greater proportion of patients with retinopathy is
women (73.7%) compared to 26.3% of men who have
the complication, we must take into account that in the
Comprehensive Diabetes Program of the CS San Genaro
de Villa the highest proportion of patients who attend it
are women (81.7%) compared to 18.3% of men. For this
reason, when we analyze by gender, we nd that the
proportion of male patients with retinopathy (22.72%)
is greater than the proportion of female patients with
said complication (14.43%). This is related to what was
found in the NHANES III from 2005 to 2008, which found
that diabetic retinopathy is slightly more frequent in
men than in women with diabetes, 31.6% (95% CI:
26.8% -36 .8%) versus 25.7% (95% CI: 21.7% -30.1%, p =
0.04). Likewise, according to NHANES III, the male sex
was independently associated with diabetic
retinopathy (odds ratio [OR] = 2.07, 95% CI: 1.39-3.10).

This higher frequency of diabetic retinopathy in older
adults could be related to the longer time living with the
underlying disease and, therefore, greater exposure to
chronic hyperglycemia, a preponderant
pathophysiological factor in the appearance of said
microvascular complication.
When the prevalence of retinopathy is described
according to the time of illness, the average time of
illness of patients with diabetic retinopathy is slightly
higher than that of patients who do not present the
complication. In relation to the time of illness, various
studies such as the NHANES III Survey nd that this
factor is independently associated with the presence of
retinopathy (OR: 1.06 per year of duration, CI 95%: 1.031.10), data that is corroborated by Afra A Al-Sarraf et
al.(14) who found that the duration of diabetes is a
signi cant predictor of diabetic retinopathy (OR=2.6,
95% CI: 1.61-4.2) .
Studies such as the Diabetes Control and Complications
Trial (DCCT) and the United Kingdom Prospective
Diabetes Study (UKPDS) have shown that chronic
hyperglycemia is a preponderant factor in the induction
of retinal lesions, from which we can infer that a longer
duration of disease would be associated with a greater
probability of developing long-standing
hyperglycemia and subsequent retinal lesions.
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When we describe the prevalence of retinopathy
according to the type of treatment, we can see that the
majority of patients with retinopathy use oral
antidiabetics (89.5%) compared to 10.5% of patients
with the complication who already use insulin. either
alone or in combination with oral antidiabetics. If we
analyze by treatment groups the total number of
patients who receive only Oral antidiabetics, 15.88%
have Diabetic Retinopathy, and in the case of patients
who receive oral antidiabetic therapy plus insulin, 20%
have Diabetic Retinopathy. This slight numerical
superiority in the prevalence of retinopathy in insulindependent patients is related to what was found in
other investigations, such as the NHANES III from 2005
to 2008, which reported that the use of insulin was
independently associated with the presence of
retinopathy (OR, 3.23, 95% CI: 1.99 to 5.26). Researchers
such as Afra A Al-Sarraf et al.(14) , also found that patients
with diabetes mellitus treated with insulin were more
likely to develop diabetic retinopathy (OR=8, 95% CI:
3.5-19.4. At, Juan Amaral Luna et al. (11) found that the
type of treatment was a factor related to the
appearance of diabetic retinopathy.
When we analyzed the prevalence of diabetic
retinopathy according to total cholesterol, LDL-C, HDLC or triglycerides, we did not observe a numerically
important diﬀerence in both groups with and without
retinopathy, this could be since many of the patients of
the Comprehensive Diabetes Program of CS San Genaro
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de Villa who present with dyslipidemia receive lipidlowering treatment to treat said alteration of lipid
metabolism, which could make the numerical
diﬀerence to which we refer imperceptibly.This would
be related to the ndings found when we evaluated the
variable prevalence of diabetic retinopathy according
to the history of dyslipidemia in which we can rather
appreciate that the highest proportion (57.%) of
patients who have retinopathy have a history of
dyslipidemia while on the other hand, of patients who
do not have retinopathy the largest proportion (51.5%)
do not have the history.
When we evaluate the prevalence of retinopathy
according to values of systolic blood pressure (SBP), and
diastolic blood pressure (DBP) in the patients studied,
we nd that the average SBP in patients with
retinopathy is 154.474 mmHg, while in patients who do
not have the complication the average is 133.940
mmHg, to DBP the averages are respectively: 74.211
mmHg and 69.820 mmHg. In both cases, whether SBP
or DBP, patients with diabetic retinopathy have a higher
average blood pressure than those who do not have the
complication; These descriptive data are related to the
analytical ndings of studies such as the NHANES III, in
which SBP was found to be independently associated
with the presence of diabetic retinopathy (OR, 1.03 per
mm Hg; 95% CI: 1.02-1.03). Concerning blood pressure
and its impact on the induction of retinal lesions,
current evidence supports that control of arterial
hypertension reduces the rate of progression of
diabetic retinopathy and reduces the risk of vitreous
hemorrhage.
Studies such as the United Kingdom Prospective
Diabetes Study (UKPDS) found that after eight to nine
years of intervention, the group of patients with lower
blood pressure had a 24% reduction in diabetes-related
endpoints and a 34% and 47% reduction in signi cantly
impaired retinopathy and visual acuity, respectively.
The improvement was manifested in all aspects:
microaneurysms, hard exudates, cotton wool exudates,
progression of retinopathy, need for photocoagulation,
and blindness. Hence the importance of control. a
comprehensive study of blood pressure in this group of
patients.
The prevalence of diabetic retinopathy according to
Body Mass Index (BMI) in patients with and without
retinopathy, a slightly higher average BMI was found in
patients who do not have the complication; these data
diﬀer from those found by T eresa Mendizábal et al.

in 2010, who after evaluating 48 patients with diabetes
mellitus found that the average BMI at the time of
evaluation was 29.5 and 25.9 for patients with and
without microangiopathy, respectively. In this last
study, as we can see, the patients with retinopathy had a
higher BMI than those without the complication, which
is the opposite of that found in the present
investigation.
This could be explained by the sample size included in
the investigation by Mendizábal et al., which only
included 48 diabetic patients. On the other hand, we
must take into account that it is likely that patients who
already have micro or macrovascular complications and
who are included in a comprehensive program that
re i n fo rc e s t h e p ro m o t i o n a l, a n d p re ve n t i ve
component, further intensify aspects such as nutrition
and physical activity with the consequent impact on
clinical anthropometric measurements and although
obesity is associated with retinopathy, it is not clear if it
is an independent factor or if it acts through other
factors, such as the increased prevalence of arterial
hypertension, hyperlipidemia or worse metabolic
control(15,16) .
When we describe the study variable prevalence of
diabetic retinopathy according to glycosylated
hemoglobin (HbA1c), we can see that the average value
in patients with and without retinopathy is practically
the same (8.4489 vs 8.7283). Again, surveys such as the
NHANES III found that diabetic retinopathy was
independently associated with a higher level of
glycosylated hemoglobin (OR, 1.45; 95% CI: 1.20-1.75).
Afra A Al-Sarraf et al. (14) also found that poor glycemic
control were associated with the appearance of retinal
lesions in diabetic patients (OR=2.0, 95% CI: 1.2-2.8).
The UKPDS study (17) found that a 0.9% reduction in
HbA1c over ten years of follow-up in patients with
newly diagnosed type II diabetes mellitus decreased
the onset and progression of retinopathy by 25%. At 6
years of follow-up of 1,216 patients who did not have
retinopathy at diagnosis, 22% developed some type of
lesion, and of 703 who did at baseline, 29% worsened.
The incidence and progression were related to the
degree of control (18) .

(12)
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One way to assess kidney function and compromise in

retinopathy. Various population studies have shown

diabetic patients is by determining creatinine clearance

that the risk of cataracts is greater in the diabetic

and quantifying microscopic albumin loss called

population. In a study (19) conducted in an Australian

microalbuminuria. Precisely, evaluating these

population, diabetes mellitus (DM) involved a relative

laboratory parameters allows us to identify other

risk of posterior subcapsular cataracts of 1.7 to 5.1. Snell

microvascular complications of the diabetic patient,

Sterling's visual eﬃciency is a way of expressing a

such as nephropathy. In our study, we can appreciate

person's degree of visual engagement as a percentage.

the Prevalence of Diabetic Retinopathy according to

As we can see from the Prevalence of Diabetic

Creatinine Clearance that the average of this parameter

Retinopathy according to Right Eye Visual Eﬃciency

in patients with retinopathy is lower than patients

and Prevalence of Diabetic Retinopathy according to

without the complication (90.3653 ml/min vs 112.1364

Left Eye Visual Eﬃciency, the average visual eﬃciency

ml/min respectively), which implicitly re ects a greater

calculated in both eyes is higher in patients without

deterioration of renal function in the rst group of

retinopathy than in those with microangiopathic

patients.

complications. which is a logical consequence of less
retinal compromise and, therefore, better visual acuity

On the other hand, the Prevalence of Diabetic

in the former. Precisely, Manuel E. Licea Puig et al. (20) ,

Retinopathy according to Microalbuminuria, the

after evaluating 110 diabetic patients with retinopathy,

average of this parameter in patients with retinopathy is

found 65.9% of them with visual eﬃciency below 84%, a

higher than those who do not have the complication

value that when contrasted with our retinopathic

(356.93 mg/dl/24 hours vs 36.7440 mg/dl/24 hours)

population rises to 100%, that is, in our study all patients

already re ecting renal compromise in the former.

with retinopathy have a visual eﬃciency below the

These descriptive data are related to the ndings of Afra

value found by Licea. Let us remember that the

A Al-Sarraf et al.

, who found that nephropathy was

decrease in visual acuity that cannot be corrected with

signi cantly associated with diabetic retinopathy. The

refraction constitutes one of the main clinical

association between the development of diabetic

manifestations of diabetic patients with retinopathy.

(14)

retinopathy and nephropathy, independent of the
degree of hyperglycemia and the duration of diabetes,

If we evaluate the prevalence of diabetic retinopathy

suggests that common pathogenic factors may

according to bilateral ocular pressure in both groups of

underlie the development of both complications.

patients with and without retinopathy, we will see,
according to our results, that the average ocular

When we evaluate the prevalence of diabetic

pressure is practically similar (15.5632 mmHg and

retinopathy according to associated ocular pathology,

15.9910 in the right eye; 15 .7842 and 16.4590 mmHg in

we can see that cataract was the most frequent
pathology in patients with retinopathy, with a 52.6%
prevalence in this group. However, when we subanalyze by type of pathology in both groups of patients

the left eye, for patients with and without retinopathy,
respectively). There is no agreement on whether DM
poses an increased risk of glaucoma. Some studies
observe twice the risk among the population with DM

with and without retinopathy, we see that of the total

(21)

number of patients with cataracts, 71.4% do not have

(22,23)
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